NCT00145418View on ClinicalTrials.gov

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

March 31, 2010

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

Oxaliplatin + Docetaxel

Oxaliplatin 85mg/m2 Docetaxel 30mg.m2

Trial Locations (1)

60068

Oncology Specialists, SC, Park Ridge

Sponsors

Collaborators (1)

Sanofi-Synthelabo

All Listed Sponsors

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

Oncology Specialists, S.C.

OTHER